Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 2
2001 1
2002 2
2007 1
2008 1
2009 1
2010 3
2011 4
2012 6
2013 4
2014 2
2015 4
2016 3
2017 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda.
Reynolds SJ, Ssempijja V, Galiwango R, Ndyanabo A, Nakigozi G, Lyagoba F, Nazziwa J, Redd A, Lamers SL, Gray R, Wawer M, Serwadda D, Quinn TC. Reynolds SJ, et al. Among authors: lyagoba f. AIDS Res Hum Retroviruses. 2017 May;33(5):448-451. doi: 10.1089/AID.2015.0370. Epub 2016 Nov 28. AIDS Res Hum Retroviruses. 2017. PMID: 27798967 Free PMC article.
Field study of dried blood spot specimens for HIV-1 drug resistance genotyping.
Parry CM, Parkin N, Diallo K, Mwebaza S, Batamwita R, DeVos J, Bbosa N, Lyagoba F, Magambo B, Jordan MR, Downing R, Zhang G, Kaleebu P, Yang C, Bertagnolio S. Parry CM, et al. Among authors: lyagoba f. J Clin Microbiol. 2014 Aug;52(8):2868-75. doi: 10.1128/JCM.00544-14. Epub 2014 May 28. J Clin Microbiol. 2014. PMID: 24871219 Free PMC article.
Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa.
Sutherland KA, Goodall RL, McCormick A, Kapaata A, Lyagoba F, Kaleebu P, Thiltgen G, Gilks CF, Spyer M, Kityo C, Pillay D, Dunn D, Gupta RK; DART Virology Group; DART Trial Team. Sutherland KA, et al. Among authors: lyagoba f. AIDS Res Hum Retroviruses. 2015 Oct;31(10):1032-7. doi: 10.1089/aid.2015.0138. Epub 2015 Aug 10. AIDS Res Hum Retroviruses. 2015. PMID: 26258548 Free PMC article.
High rate of HIV resuppression after viral failure on first-line antiretroviral therapy in the absence of switch to second-line therapy.
Gupta RK, Goodall RL, Ranopa M, Kityo C, Munderi P, Lyagoba F, Mugarura L, Gilks CF, Kaleebu P, Pillay D; DART Virology Group and Trial Team. Gupta RK, et al. Among authors: lyagoba f. Clin Infect Dis. 2014 Apr;58(7):1023-6. doi: 10.1093/cid/cit933. Epub 2013 Dec 18. Clin Infect Dis. 2014. PMID: 24352348 Free PMC article. Clinical Trial.
HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach.
Kiwuwa-Muyingo S, Nazziwa J, Ssemwanga D, Ilmonen P, Njai H, Ndembi N, Parry C, Kitandwe PK, Gershim A, Mpendo J, Neilsen L, Seeley J, Seppälä H, Lyagoba F, Kamali A, Kaleebu P. Kiwuwa-Muyingo S, et al. Among authors: lyagoba f. PLoS One. 2017 Oct 12;12(10):e0185818. doi: 10.1371/journal.pone.0185818. eCollection 2017. PLoS One. 2017. PMID: 29023474 Free PMC article. Clinical Trial.
Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda.
Kaleebu P, Whitworth J, Hamilton L, Rutebemberwa A, Lyagoba F, Morgan D, Duffield M, Biryahwaho B, Magambo B, Oram J. Kaleebu P, et al. Among authors: lyagoba f. AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):393-401. doi: 10.1089/088922200309052. AIDS Res Hum Retroviruses. 2000. PMID: 10772525
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
Kaleebu P, Kirungi W, Watera C, Asio J, Lyagoba F, Lutalo T, Kapaata AA, Nanyonga F, Parry CM, Magambo B, Nazziwa J, Nannyonjo M, Hughes P, Hladik W, Ruberantwari A, Namuwenge N, Musinguzi J, Downing R, Katongole-Mbidde E; HIV Drug Resistance Working group. Kaleebu P, et al. Among authors: lyagoba f. PLoS One. 2015 Dec 23;10(12):e0145536. doi: 10.1371/journal.pone.0145536. eCollection 2015. PLoS One. 2015. PMID: 26700639 Free PMC article.
Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
Sutherland KA, Parry CM, McCormick A, Kapaata A, Lyagoba F, Kaleebu P, Gilks CF, Goodall R, Spyer M, Kityo C, Pillay D, Gupta RK; DART Virology Group. Sutherland KA, et al. Among authors: lyagoba f. PLoS One. 2015 Sep 18;10(9):e0137834. doi: 10.1371/journal.pone.0137834. eCollection 2015. PLoS One. 2015. PMID: 26382239 Free PMC article. Clinical Trial.
30 results